Development of Cyclopropyl Metal Carbene Based Methods for Organic Synthesis

描述(申请人提供)：作为一项研究计划的一部分，致力于开发有机化学和制药科学中新的催化化学、区域和立体选择性合成方法，将开发基于环丙基金属卡宾的化学方法，用于在温和的催化条件下合成高度官能化的环丁烷、吡喃和其他复杂环系。环丙基金属卡宾在各种过渡金属催化剂作用下的反应活性的发现，为环丙烷和金属卡宾的化学研究开辟了一系列独特的途径，提高了我们对环丙烷和金属卡宾化学的基本认识。在目标1中，我们建议开发：a)合成芳基和烷基取代的环丙基重氮化合物的一般方法，并探索这些重氮化合物在过渡金属催化剂(例如：镝(II)、铜(I)和银(I))存在下的化学、区域和立体选择性；b)从介孔重氮化合物制备手性环丁烯的不对称扩环反应；以及c)合成吡喃衍生物的一般方法。在目标2中，我们建议基于我们在初步研究中开发的方法和目标1中提出的方法，开发一种统一而灵活的方法来合成手性环丁烷。我们在这里建议实现的天然产物具有广泛的生物活性，包括抗生素、抗病毒药物、抗微生物药物、止痛药、选择性CYP抑制剂和组胺H3受体拮抗剂。在目标#3中，我们建议将环丙基金属卡宾的反应性从通过重排形成环丁烯和4H-吡喃扩大到通过环加成形成更复杂的环系。相关系统的计算结果被用来指导几个环加成反应的设计。基于过渡金属催化剂能够形成金属卡宾、催化环加成反应和裂解环丙烷C-C键的性质，选择了过渡金属催化剂用于这些环加成反应。这些研究将极大地提高环丙烷和金属卡宾的合成效用，并使以前未知的环丙烷和金属卡宾的反应得以发现。这些目标的累积结果是提高了对环丙烷和各种金属卡宾化学的基本了解，并发现了在合成复杂有机分子方面立即有用的有效方法。与公共健康相关：概述的提案提供了快速、高效和立体选择性地获得重要的生物活性天然产品和候选药物的途径。该提案中开发的合成方法也很灵活，可以制造许多潜在的更有效的类似物，这可能会更有效地治疗人类疾病。

DESCRIPTION (provided by applicant): As part of a research program focused on the development of new catalytic chemo-, regio-, and stereoselective synthetic methods for organic chemistry and pharmaceutical sciences, chemical methods based on cyclopropyl metal carbenes will be developed for the synthesis of highly functionalized cyclobutanes, pyrans, and other complex ring systems under mild catalytic conditions. The discovery of the novel reactivity of cyclopropyl metal carbenes, mediated by various transition metal catalysts, opens a broad range of mechanistically unique pathways and improves our fundamental understanding for the chemistry of cyclopropanes and metal carbenes. In aim #1, we propose to develop: a) general methods for the preparation of aryl and alkyl substituted cyclopropyl diazo compounds and explore the chemo-, regio-, and stereoselectivity of the ring expansion of these diazo compounds in the presence of transition metal catalysts (e.g. dirhodium (II), copper (I), and silver (I)); b) an enantioselective ring expansion reaction to prepare chiral cyclobutenes from meso diazo compounds; and c) general methods for the preparation of pyran derivatives. In aim #2, we propose to develop a unified and flexible strategy for the diastereo- and enantioselective synthesis of chiral cyclobutanes based on methods we developed in preliminary study and methods proposed in aim #1. Natural products that we propose to accomplish here have broad biological activities, including antibiotics, antiviral agents, antimicrobial agents, analgesics, selective CYP inhibitors, and histamine H3 receptor antagonists. In aim #3, we propose to expand the reactivity profile of cyclopropyl metal carbenes from the formation of cyclobutenes and 4H-pyrans via rearrangement to the formation of more complex ring systems via cycloadditions. Computational results from related systems were used to guide the design of several cycloaddition reactions. Transition metal catalysts were chosen for these cycloadditions based on their properties of being able to form metal carbenes, to catalyze cycloaddition reactions, and to cleave cyclopropane C-C bonds. These studies together will greatly increase the synthetic utility of cyclopropanes and metal carbenes and enable the discovery of previously unknown reactions of cyclopropanes and metal carbenes. The cumulative result of these aims is improved fundamental understanding of the chemistry of cyclopropanes and various metal carbenes and discovery of efficient methods that will find immediate utility in the synthesis of complex organic molecules. PUBLIC HEALTH RELEVANCE: The outlined proposal provides access to important biologically active natural products and drug candidates rapidly, efficiently, and stereoselectively. Synthetic methods developed in this proposal are also flexible to make many potentially more potent analogs, which may cure human diseases more effectively.